Early Parkinson’s patients with high coffee consumption had 8% to 15% lower dopamine transporter binding compared with low coffee drinkers, but no significant effects on symptoms, including motor function, were seen. (Annals of Neurology)
Lewy body dementia showed distinct changes in vocal emotional expression compared with Alzheimer’s disease, an analysis of voice data showed. (Alzheimer’s & Dementia)
One in eight older Americans was diagnosed with traumatic brain injury during an 18-year study period. (JAMA Network Open)
Neurofilament light is inching its way toward formally qualifying as a biomarker of frontotemporal degeneration, the Foundation for the National Institutes of Health reported.
Undiagnosed memory disorders can create large adverse changes in net wealth and credit outcomes, according to a Federal Reserve Bank of New York report.
Astrocytic signaling may have different cognitive effects in females and males. (Cell Reports)
Here’s how humans distinguish music from speech. (PLOS Biology)
People were likely to participate in clinical trials of neurodegenerative diseases due to their relationship with clinical staff, a meta-analysis showed. (Neurology)
New trials investigated the use of rozanolixizumab (Rystiggo) and rituximab in chronic inflammatory demyelinating polyneuropathy (CIDP). (Journal of Neurology, Neurosurgery, and Psychiatry)
Investigational arimoclomol, a heat-shock protein-70 (HSP70) co-inducer, did not improve efficacy outcomes in a phase III amyotrophic lateral sclerosis (ALS) trial. (Lancet Neurology)
-
Judy George covers neurology and neuroscience news for MedPage Today, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more. Follow
Please enable JavaScript to view the